ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Blue Chip Shares
2 of the best ASX 200 blue chip shares to buy with $2,000
Healthcare Shares
Which ASX 200 healthcare share will pay the best dividend yield in 2025?
Dividend Investing
Looking to bag the record high ResMed dividend? You better hurry!
How to invest
I'd invest $25 a week in ASX shares for a passive income in retirement
How to invest
How to build a world-class ASX share portfolio in 2025
Best Shares
6 ASX 200 shares that could benefit from a weak Australia Dollar
Broker Notes
2 Australian stocks to buy with $5,000 after the market selloff
Broker Notes
Leading brokers name 3 ASX shares to buy today
Healthcare Shares
Down 4%, is the ResMed share price in the buy zone?
Share Market News
5 things to watch on the ASX 200 on Monday
Best Shares
Top ASX shares to buy in February 2025
Earnings Results
ResMed shares rise on strong Q2 result
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.